These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 30472657)
21. A comprehensive study of oculocutaneous albinism type 1 reveals three previously unidentified alleles on the TYR gene. Lin YY; Wei AH; He X; Zhou ZY; Lian S; Zhu W Eur J Dermatol; 2014; 24(2):168-73. PubMed ID: 24721949 [TBL] [Abstract][Full Text] [Related]
22. A novel missense mutation of the TYR gene in a pedigree with oculocutaneous albinism type 1 from China. Lin YY; Wei AH; Zhou ZY; Zhu W; He X; Lian S Chin Med J (Engl); 2011 Oct; 124(20):3358-61. PubMed ID: 22088535 [TBL] [Abstract][Full Text] [Related]
23. NGS-based targeted sequencing identified two novel variants in Southwestern Chinese families with oculocutaneous albinism. Xiao Y; Zhou C; Xie H; Huang S; Wang J; Liu S BMC Genomics; 2022 Apr; 23(1):332. PubMed ID: 35488210 [TBL] [Abstract][Full Text] [Related]
25. Novel mutations of the tyrosinase (TYR) gene in type I oculocutaneous albinism (OCA1). Spritz RA; Oh J; Fukai K; Holmes SA; Ho L; Chitayat D; France TD; Musarella MA; Orlow SJ; Schnur RE; Weleber RG; Levin AV Hum Mutat; 1997; 10(2):171-4. PubMed ID: 9259202 [No Abstract] [Full Text] [Related]
26. Identification and characterization of two novel noncoding tyrosinase (TYR) gene variants leading to oculocutaneous albinism type 1. Li C; Chen Q; Wu J; Ren J; Zhang M; Wang H; Li J; Tang Y J Biol Chem; 2022 May; 298(5):101922. PubMed ID: 35413289 [TBL] [Abstract][Full Text] [Related]
27. Identification and characterization of the compound heterozygous variants of TYR gene in a northern Chinese family with Oculocutaneous albinism type 1. Si S; Jia X; Xu L; Qin Q; Wu J; Ji W; Dong K; Zhang X; Cao L; Wang H; Liu P; Wang R; Bai J; Fu S; Huang Y; Sun W Pigment Cell Melanoma Res; 2023 Nov; 36(6):472-480. PubMed ID: 37403904 [TBL] [Abstract][Full Text] [Related]
28. Mapping the TYR gene reveals novel and previously reported variants in Eastern Indian patients highlighting preponderance of the same changes in multiple unrelated ethnicities. Ganguly K; Dutta T; Saha A; Sarkar D; Sil A; Ray K; Sengupta M Ann Hum Genet; 2020 May; 84(3):303-312. PubMed ID: 32115698 [TBL] [Abstract][Full Text] [Related]
29. Functional assessment of tyrosinase variants identified in individuals with albinism is essential for unequivocal determination of genotype-to-phenotype correlation. Mondal M; Sengupta M; Ray K Br J Dermatol; 2016 Dec; 175(6):1232-1242. PubMed ID: 27537549 [TBL] [Abstract][Full Text] [Related]
30. Mutation spectrum of the TYR and SLC45A2 genes in patients with oculocutaneous albinism. Ko JM; Yang JA; Jeong SY; Kim HJ Mol Med Rep; 2012 Apr; 5(4):943-8. PubMed ID: 22294196 [TBL] [Abstract][Full Text] [Related]
31. Mutational spectrum of the TYR and SLC45A2 genes in Pakistani families with oculocutaneous albinism, and potential founder effect of missense substitution (p.Arg77Gln) of tyrosinase. Shah SA; Raheem N; Daud S; Mubeen J; Shaikh AA; Baloch AH; Nadeem A; Tayyab M; Babar ME; Ahmad J Clin Exp Dermatol; 2015 Oct; 40(7):774-80. PubMed ID: 25703744 [TBL] [Abstract][Full Text] [Related]
32. Identification of a novel mutation (p.Ile198Thr) in gene TYR in a Pakistani family with nonsyndromic oculocutaneous albinism. Shah SA; Din SU; Raheem N; Daud S; Mubeen J; Nadeem A; Tayyab M; Baloch DM; Babar ME; Ahmad J Clin Exp Dermatol; 2014 Jul; 39(5):646-8. PubMed ID: 24934919 [TBL] [Abstract][Full Text] [Related]
33. Mutation analysis of a Chinese family with oculocutaneous albinism. Wang X; Zhu Y; Shen N; Peng J; Wang C; Liu H; Lu Y Oncotarget; 2016 Dec; 7(51):84981-84988. PubMed ID: 27829221 [TBL] [Abstract][Full Text] [Related]
34. [Study of tyrosinase gene mutation in oculocutaneous albinism type 1 patients]. Zheng H; Huang ZG; Wen RQ; Li HY Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2011 Aug; 27(3):329-32. PubMed ID: 22097729 [TBL] [Abstract][Full Text] [Related]
35. The Phenotypic Spectrum of Albinism. Kruijt CC; de Wit GC; Bergen AA; Florijn RJ; Schalij-Delfos NE; van Genderen MM Ophthalmology; 2018 Dec; 125(12):1953-1960. PubMed ID: 30098354 [TBL] [Abstract][Full Text] [Related]
36. The contribution of common regulatory and protein-coding TYR variants to the genetic architecture of albinism. Michaud V; Lasseaux E; Green DJ; Gerrard DT; Plaisant C; ; Fitzgerald T; Birney E; Arveiler B; Black GC; Sergouniotis PI Nat Commun; 2022 Jul; 13(1):3939. PubMed ID: 35803923 [TBL] [Abstract][Full Text] [Related]
37. After an initial Hermansky-Pudlak syndrome clinical diagnosis, molecular testing reveals variants for oculocutaneous albinism type 1B: A case report. Serrano-González J; Montes-RodrĂguez I; Renta JY; Rojas R; Cadilla CL Mol Genet Genomic Med; 2024 Jul; 12(7):e2493. PubMed ID: 38994739 [TBL] [Abstract][Full Text] [Related]
38. [Prenatal gene diagnosis of oculocutaneous albinism type I]. Li HY; Wu WI; Zheng H; Duan HL; Chen Z; Chen LM Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):280-2. PubMed ID: 16767664 [TBL] [Abstract][Full Text] [Related]
39. Identifying genetic defects in oculocutaneous albinism patients of West Bengal, Eastern India. Dutta T; Ganguly K; Saha A; Sil A; Ray K; Sengupta M Mol Biol Rep; 2024 Jul; 51(1):818. PubMed ID: 39014059 [TBL] [Abstract][Full Text] [Related]
40. Oculocutaneous albinism (OCA) in Colombia: first molecular screening of the TYR and OCA2 genes in South America. Urtatiz O; Sanabria D; Lattig MC J Dermatol Sci; 2014 Dec; 76(3):260-2. PubMed ID: 25455140 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]